Premium
O2‐05‐05: Results of the first‐in‐man study with the active Aβ Immunotherapy CAD106 in Alzheimer patients
Author(s) -
Winblad Bengt G.,
Minthon L.,
Floesser A.,
Imbert G.,
Dumortier T.,
He Y.,
Maguire P.,
Karlsson M.,
östlund H.,
Lundmark J.,
Orgogozo J.M.,
Graf A.,
Andreasen N.
Publication year - 2009
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2009.05.356
Subject(s) - cohort , medicine , placebo , tolerability , adverse effect , immunogenicity , immunology , pathology , antibody , alternative medicine